Viridian Therapeutics
VRDN · NASDAQ
$22.43+$0.05 (+0.22%)TodayMarket closed ·
Prev close $22.38
Who owns VRDN
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 61.1% of VRDN’s shares.
- Fidelity Management & Research Company LLC12.4%
- BlackRock Institutional Trust Company, N.A.6.1%
- Bellevue Asset Management AG6.1%
- Paradigm BioCapital Advisors LP6.1%
- Next 6 largest institutions30.4%
- All other shareholders38.9%
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Management & Research Company LLC | 13.72M | 12.42% |
| BlackRock Institutional Trust Company, N.A. | 6.78M | 6.14% |
| Bellevue Asset Management AG | 6.73M | 6.10% |
| Paradigm BioCapital Advisors LP | 6.72M | 6.09% |
| Kynam Capital Management LP | 6.45M | 5.84% |
| State Street Investment Management (US) | 6.12M | 5.55% |
| Point72 Asset Management, L.P. | 5.69M | 5.15% |
| T. Rowe Price Associates, Inc. | 5.62M | 5.08% |
| Fairmount Funds Management LLC | 5.09M | 4.61% |
| Vanguard Capital Management, LLC | 4.58M | 4.14% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| State Street SPDR S&P Biotech ETF | 4.13M | 3.74% |
| Vanguard Total Stock Market Index Fund | 3.36M | 3.04% |
| iShares Russell 2000 ETF | 2.34M | 2.12% |
| Fidelity Advisor Biotechnology Fund | 1.78M | 1.61% |
| Fidelity Select Health Care Portfolio | 1.50M | 1.36% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $20.00M (1 trade) and sold $348.19K (2 trades) of VRDN on the open market.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Tousignant Jennifer | Option exercise | 10.00K | — |
| Tousignant Jennifer | Sale | 10.00K | $245.00K |
| Tousignant Jennifer | Option exercise | 10.00K | $144.10K |
| Tousignant Jennifer | Sale | 4.21K | $103.19K |
| Tripuraneni Radhika | Option exercise | 40.00K | — |
| Tripuraneni Radhika | Option exercise | 40.00K | $528.40K |
| CAIN CHRISTOPHER W. | Award | 32.34K | — |
| Moses Jennifer K. | Award | 32.34K | — |
| Gheuens Sarah | Award | 32.34K | — |
| Kiselak Tomas | Award | 32.34K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 17.97M
- Days to cover
- 8.87
- % of shares outstanding
- 16.27%
- Average daily volume
- 2.03M
- Change since last report
- −7.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.